Polycythemia Vera : Drugs
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Drugs could include:
|
Polycythemia vera (PV) is a chronic blood disorder marked by an abnormal increase in three types of blood cells produced by bone marrow: red blood cells (RBCs), white blood cells (WBCs), and platelets. PV is called a myeloproliferative disorder, w...
|
|
Anagrelide lowers the number of blood clotting cells (called platelets) in the body. This
helps to prevent blood clots from forming.
|
|
Anagrelide, also known by the brand name Agrylin, is used to treat patients with thrombocytosis, a condition in which patients have too many platelet cells in their blood. Platelets are a cell type formed in the bone marrow that are involved in the blood clotting process.
|
|
Antineoplastic agent; exhibits beneficial effects against sickle cell anemia; exhibits antiviral activity.
|
|
Hydroxyurea, also known by its trade name Hydrea, is an antineoplastic agent, meaning it is used to treat cancer. It is taken orally.
|
|
Interferon alfa-2b is made from human proteins. Interferons help the body fight viral
infections.
|
|
Hydroxyurea affects certain cells in the body, such as cancer cells or sickled red blood
cells.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.